[
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Ascends While Market Falls: Some Facts to Note",
    "summary": "The latest trading day saw AbbVie (ABBV) settling at $220.81, representing a +2.1% change from its previous close.",
    "url": "https://finnhub.io/api/news?id=19cf630fd3e2b3b9d2b058321361b8a8d4ac1901f6af27cf35b04c32efad5df7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758149103,
      "headline": "AbbVie (ABBV) Ascends While Market Falls: Some Facts to Note",
      "id": 136797613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The latest trading day saw AbbVie (ABBV) settling at $220.81, representing a +2.1% change from its previous close.",
      "url": "https://finnhub.io/api/news?id=19cf630fd3e2b3b9d2b058321361b8a8d4ac1901f6af27cf35b04c32efad5df7"
    }
  },
  {
    "ts": null,
    "headline": "Oruka Therapeutics, Up 9%, Is Trying To Take On AbbVie's Biggest Moneymaker",
    "summary": "Biotech stock Oruka Therapeutics skyrocketed Wednesday on promising test results for what could be a once-annual shot to treat psoriasis.",
    "url": "https://finnhub.io/api/news?id=5da9b743ff810352d4c440792e2aef9f655aacdb31bc20f609f30015ff33c9cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758143403,
      "headline": "Oruka Therapeutics, Up 9%, Is Trying To Take On AbbVie's Biggest Moneymaker",
      "id": 136797614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Biotech stock Oruka Therapeutics skyrocketed Wednesday on promising test results for what could be a once-annual shot to treat psoriasis.",
      "url": "https://finnhub.io/api/news?id=5da9b743ff810352d4c440792e2aef9f655aacdb31bc20f609f30015ff33c9cd"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Edge Higher Late Afternoon",
    "summary": "Health care stocks were edging up late Wednesday afternoon, with the NYSE Health Care Index up 0.2%",
    "url": "https://finnhub.io/api/news?id=5b81c93dd0d7e72ae2d8602cd25c11a3b1652c3ee98bd19ac99c9c1b3cb7a3eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758142593,
      "headline": "Sector Update: Health Care Stocks Edge Higher Late Afternoon",
      "id": 136791560,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Health care stocks were edging up late Wednesday afternoon, with the NYSE Health Care Index up 0.2%",
      "url": "https://finnhub.io/api/news?id=5b81c93dd0d7e72ae2d8602cd25c11a3b1652c3ee98bd19ac99c9c1b3cb7a3eb"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy This Blue-Chip Dividend Stock at Record Highs?",
    "summary": "AbbVie shares have hit record highs after extending Rinvoq’s patent protection to 2037, boosting confidence in future earnings and dividend growth, with analysts seeing steady fundamentals and modest upside as the company’s immunology pipeline drives results.",
    "url": "https://finnhub.io/api/news?id=24b650d9418e258fa9121518d67610030b57afabb0d65b736f3e7b36da04a949",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758131688,
      "headline": "Should You Buy This Blue-Chip Dividend Stock at Record Highs?",
      "id": 136791593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie shares have hit record highs after extending Rinvoq’s patent protection to 2037, boosting confidence in future earnings and dividend growth, with analysts seeing steady fundamentals and modest upside as the company’s immunology pipeline drives results.",
      "url": "https://finnhub.io/api/news?id=24b650d9418e258fa9121518d67610030b57afabb0d65b736f3e7b36da04a949"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=3679ad932af996860d097a08df132aaf39823a6e1ae7bbd62441a284a694882e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758126660,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 136803814,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=3679ad932af996860d097a08df132aaf39823a6e1ae7bbd62441a284a694882e"
    }
  },
  {
    "ts": null,
    "headline": "Oruka Therapeutics, Up 10%, Is Trying To Take On AbbVie's Biggest Moneymaker",
    "summary": "Biotech stock Oruka Therapeutics skyrocketed Wednesday on promising test results for what could be a once-annual shot to treat psoriasis.",
    "url": "https://finnhub.io/api/news?id=ee260e2def821233bb144d189563793aa2f1c124280fb92d1ce80c0f4cca86a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758124230,
      "headline": "Oruka Therapeutics, Up 10%, Is Trying To Take On AbbVie's Biggest Moneymaker",
      "id": 136789910,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Biotech stock Oruka Therapeutics skyrocketed Wednesday on promising test results for what could be a once-annual shot to treat psoriasis.",
      "url": "https://finnhub.io/api/news?id=ee260e2def821233bb144d189563793aa2f1c124280fb92d1ce80c0f4cca86a0"
    }
  },
  {
    "ts": null,
    "headline": "Netflix upgraded, Five Below initiated: Wall Street's top analyst calls",
    "summary": "Netflix upgraded, Five Below initiated: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=6f04ba293e7bafcfb5742f154a80a10737b7e5f994c48bd5f4c727370ba6ed17",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758119599,
      "headline": "Netflix upgraded, Five Below initiated: Wall Street's top analyst calls",
      "id": 136789007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Netflix upgraded, Five Below initiated: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=6f04ba293e7bafcfb5742f154a80a10737b7e5f994c48bd5f4c727370ba6ed17"
    }
  },
  {
    "ts": null,
    "headline": "Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker",
    "summary": "Biotech stock Oruka Therapeutics skyrocketed Wednesday on promising test results for what could be a once-annual shot to treat psoriasis.",
    "url": "https://finnhub.io/api/news?id=db898ca010280bc16b8b0bd40a4cd7b715948542b52dc46f6e618e30548e30fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758119180,
      "headline": "Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker",
      "id": 136789030,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Biotech stock Oruka Therapeutics skyrocketed Wednesday on promising test results for what could be a once-annual shot to treat psoriasis.",
      "url": "https://finnhub.io/api/news?id=db898ca010280bc16b8b0bd40a4cd7b715948542b52dc46f6e618e30548e30fe"
    }
  },
  {
    "ts": null,
    "headline": "Berenberg Upgrades AbbVie (ABBV)",
    "summary": "Berenberg Upgrades AbbVie (ABBV)",
    "url": "https://finnhub.io/api/news?id=c71f049158b905d875d82a2300539b5576b8852e235dfae1b9f5a05a1aebcc57",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758109108,
      "headline": "Berenberg Upgrades AbbVie (ABBV)",
      "id": 136787220,
      "image": "",
      "related": "ABBV",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=c71f049158b905d875d82a2300539b5576b8852e235dfae1b9f5a05a1aebcc57"
    }
  }
]